» Authors » Robin J McAnulty

Robin J McAnulty

Explore the profile of Robin J McAnulty including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 2133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chin D, Hernandez-Beeftink T, Donoghue L, Guillen-Guio B, Guillen-Uio B, Leavy O, et al.
medRxiv . 2025 Feb; PMID: 39974050
Background: Idiopathic pulmonary fibrosis (IPF) is a rare, incurable lung disease with a median survival of 3-5 years after diagnosis. Treatment options are limited. Genetic association studies can identify new...
2.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
ERJ Open Res . 2024 Feb; 10(1). PMID: 38375425
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...
3.
Leavy O, Goemans A, Stockwell A, Allen R, Guillen-Guio B, Hernandez-Beeftink T, et al.
medRxiv . 2024 Jan; PMID: 38293162
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition that is more prevalent in males than females. The reasons for this are not fully understood, with differing environmental exposures...
4.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
medRxiv . 2023 Aug; PMID: 37546732
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...
5.
Prele C, Miles T, Pearce D, ODonoghue R, Grainge C, Barrett L, et al.
Eur Respir J . 2022 Jul; 60(5). PMID: 35798357
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease associated with chronic inflammation and tissue remodelling leading to fibrosis, reduced pulmonary function, respiratory failure and death. Bleomycin (Blm)-induced lung fibrosis...
6.
Prele C, Iosifidis T, McAnulty R, Pearce D, Badrian B, Miles T, et al.
Biomedicines . 2021 May; 9(5). PMID: 33946612
The interleukin (IL)-6 family of cytokines and exaggerated signal transducer and activator of transcription (STAT)3 signaling is implicated in idiopathic pulmonary fibrosis (IPF) pathogenesis, but the mechanisms regulating STAT3 expression...
7.
Guillotin D, Taylor A, Plate M, Mercer P, Edwards L, Haggart R, et al.
Thorax . 2020 Nov; 76(1):73-82. PMID: 33214245
Introduction: Fibroblastic foci represent the cardinal pathogenic lesion in idiopathic pulmonary fibrosis (IPF) and comprise activated fibroblasts and myofibroblasts, the key effector cells responsible for dysregulated extracellular matrix deposition in...
8.
Allen R, Guillen-Guio B, Oldham J, Ma S, Dressen A, Paynton M, et al.
Am J Respir Crit Care Med . 2019 Nov; 201(5):564-574. PMID: 31710517
Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide...
9.
Abayasiriwardana K, Wood M, Prele C, Birnie K, Robinson B, Laurent G, et al.
Biochem Biophys Res Commun . 2019 Jan; 510(2):198-204. PMID: 30685089
Malignant mesothelioma is an aggressive fibrous tumor, predominantly of the pleura, with a very poor prognosis. Cell-matrix interactions are recognized important determinants of tumor growth and invasiveness but the role...
10.
Patel J, Shen L, Hall S, Benyahia C, Norel X, McAnulty R, et al.
Int J Mol Sci . 2018 Aug; 19(8). PMID: 30103548
Prostacyclins are extensively used to treat pulmonary arterial hypertension (PAH), a life-threatening disease involving the progressive thickening of small pulmonary arteries. Although these agents are considered to act therapeutically via...